3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
3
Phase 1/2
2
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Carcinoma, Renal Cell
9
Sarcoma
4
Neoplasms
2
Neoplasm Metastasis
2
Patient Preference
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Ovarian Neoplasms
1
Kidney Neoplasms
1
Hemangiosarcoma
1
Fallopian Tube Neoplasms
1
Interventions
Ifosfamide
8
Doxorubicin
7
Radiotherapy
6
Chemotherapy, Adjuvant
3
Neoadjuvant Therapy
2
Filgrastim
2
Etoposide
2
pegfilgrastim
1
pazopanib
1
indolepropanol phosphate
1
carotuximab
1
Watchful Waiting
1
Vincristine
1
Radiotherapy, Conformal
1
Observation
1
Epirubicin
1
Diathermy
1
Dactinomycin
1
Cyproheptadine
1
Cyclophosphamide
1
Combined Modality Therapy
1
Carboplatin
1
Brachytherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Hemangiosarcoma
×
pazopanib
×
Clear all
NCT02979899
2020-05-12
TAPPAS
Tracon Pharmaceuticals Inc.
Phase 3
Completed
128 enrolled
13 charts